National Center for Advancing Translational Sciences
Clinical and Translational Science Institute, University of California, Los Angeles
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Feasibility of frequent monitoring of symptoms using the PRO-CTCAE in the NRG-BR004 clinical trial
Reena S. Cecchini, Jennifer Marie Suga, Mourad Tighiouart, William Irvin et al.
Journal
JNCI Cancer Spectrum
Topics
Statistical Methods in Clinical Trials
article
Feasibility of frequent monitoring of symptoms using the PRO-CTCAE in the NRG-BR004 clinical trial
Reena S. Cecchini, Jennifer Marie Suga, Mourad Tighiouart, William Irvin, Vinícius F. Calsavara, Michael Luu, Ron D. Hays, Greg Yothers, N. Lynn Henry, Hanna Bandos, Peter Ganz, Kit Lu, Gillian Gresham, André Rogatko, Sungjin Kim, S Siddique
article en
Abstract
No abstract available for this paper.
Publication Tag
JNCI Cancer SpectrumVol. 9(3)
Institutions
Cedars-Sinai Medical Center (US), RAND Corporation (US), St. Francis Medical Center (US), University of California, Los Angeles (US), University of Pittsburgh (US), University of Michigan (US), UCLA Health (US), Southeast Clinical Oncology Research Consortium (US), Department of Health (TW), USC Norris Comprehensive Cancer Center (US), Creative Commons (US), Kaiser Permanente Vallejo Medical Center (US), UPMC Hillman Cancer Center (US), University of Pittsburgh Medical Center (US), NRG Oncology (US), UCLA Jonsson Comprehensive Cancer Center
Funders
NRG Oncology, National Institutes of Health, Genentech, National Cancer Institute, National Center for Advancing Translational Sciences, Clinical and Translational Science Institute, University of California, Los Angeles